#1022, Moffitt Cancer Center — Tampa, Florida

#1022, Moffitt Cancer Center is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

#1022, Moffitt Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Adult Solid Tumor, Advanced Solid Tumor.

Sponsors: Debiopharm International SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for #1022, Moffitt Cancer Center?

#1022, Moffitt Cancer Center has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has #1022, Moffitt Cancer Center conducted?

#1022, Moffitt Cancer Center has 2 clinical trials on record. Their work covers Adult Solid Tumor, Advanced Solid Tumor.

Is #1022, Moffitt Cancer Center accredited by Crixeo Clinical Trials?

#1022, Moffitt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about #1022, Moffitt Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.